Journal
PEDIATRIC RESEARCH
Volume 84, Issue 1, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41390-018-0077-x
Keywords
-
Categories
Funding
- EU FP7/2007-2013 [260777]
- National Institute of Health Research, Health Technology Assessment (HTA) [11/92/15]
- ZonMw Grant (The Netherlands Organization for Health Research Development) [843002622]
- European Society for Paediatric Research (ESPR)
Ask authors/readers for more resources
In many preterm infants, the ductus arteriosus remains patent beyond the first few days of life. This prolonged patency is associated with numerous adverse outcomes, but the extent to which these adverse outcomes are attributable to the hemodynamic consequences of ductal patency, if at all, has not been established. Different treatment strategies have failed to improve short-term outcomes, with a paucity of data on the correct diagnostic and pathophysiological assessment of the patent ductus arteriosus (PDA) in association with long-term outcomes. Echocardiography is the selected method of choice for detecting a PDA, assessing the impact on the preterm circulation and monitoring treatment response. PDA in a preterm infant can result in pulmonary overcirculation and systemic hypoperfusion, Therefore, echocardiographic assessment should include evaluation of PDA characteristics, indices of pulmonary overcirculation with left heart loading conditions, and indices of systemic hypoperfusion. In this review, we provide an evidence-based overview of the current and emerging ultrasound measurements available to identify and monitor a PDA in the preterm infant. We offer indications and limitations for using Neonatologist Performed Echocardiography to optimize the management of a neonate with a PDA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available